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Can It Really Be That Simple?*David Oxborough, PHD, Rachel Lord, BSCE chocardiography plays an important role inthe diagnosis and monitoring of cardiac struc-ture and function in patients with pulmonary
arterial hypertension (PAH) (1). The routine ap-
plication of resting echocardiography allows for the
noninvasive assessment of pulmonary and right ven-
tricular (RV) pressures, as well as the determination
of the progression of (mal)adaptive remodeling of
the RV cavity (2). Although there is a clear link be-
tween the severity of the disease and the extent of
RV remodeling, there is limited evidence to suggest
that echocardiography alone has prognostic value.
Some large studies have attempted to develop a pre-
dictive model for mortality risk stratiﬁcation in PAH
and established that echocardiography is mainly
redundant. In 1991, the National Institutes of Health
provided the ﬁrst prognostic equation; however, in
view of changes in disease classiﬁcations and an
advancement in both therapy and technology, the
REVEAL (Registry to Evaluate Early and Long-Term
PAH Disease Management) study in 2010 (3) provided
a more up-to-date mortality risk stratiﬁcation model
for PAH. This model utilizes a range of demographic,
clinical, and diagnostic criteria, providing reasonable
sensitivity and speciﬁcity. That aside, the criteria are
numerous and the model is complex, requiring the
use of multiple investigations with little reliance on
the structural or functional remodeling of the RV.
Furthermore, a relatively recent statement from the
American College of Cardiology Foundation stated
that echocardiography alone holds little predictive
value (4). From a pathophysiological viewpoint,*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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leads to what we consider a right heart failure syn-
drome, and therefore we would expect the degree
of RV remodeling and dysfunction to be directly
linked to mortality, as is the case in left-sided heart
failure. In addition, exercise limitation is a strong
predictor of prognosis in PAH (2), whereas right ven-
tricular failure contributes signiﬁcantly to reduced
exercise tolerance primarily through a reduced car-
diac index but also secondary to peripheral ﬂuid
retention.
The disparity between what we expect and what
we observe should lead one to question the validity
of the applied measurements. In this setting, the
applied measurements relate to the assessment of
right heart structure and function. It is feasible that
previous work has failed to acknowledge the complex
holistic nature of the right heart and the interaction
between the right atrium (RA) and the RV. Moreover,
the complex shape of the RV and its ﬁber alignment
dictates equally complex mechanics. RV function is
inﬂuenced by a range of factors, including those that
affect preload and afterload, such as respiration,
gravity, pulmonary vascular resistance, and direct
factors related to the structural integrity of the right-
sided myocardium, such as intrinsic contractility,
relaxation, and compliance (5). In the presence of an
acute increase in RV afterload, the workload of the
ventricle increases, causing prolonged isovolumic
time periods that are normally minimal. In turn, this
directly inﬂuences the RA-RV relationship, causing a
reduction in the RA-RV pressure gradient and
reducing the overall early diastolic ﬂow and ulti-
mately reducing the kinetic energy available for
ejection. This makes the RV less energy efﬁcient.
Consequently, a change will occur in RA volumes
across the cardiac cycle to increase preload or alter-
natively enhance the active booster function. When
faced with a chronic elevation in RV afterload, as
seen in PAH, the RV remodels and changes its
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640mechanical contribution to output; however, this
further inﬂuences the RA-RV relationship, with dila-
tion of the RA a likely manifestation. It is this
consideration of the complexity of load, the RA-RV
interaction, and RV structural and functional re-
modeling that is frequently lacking.SEE PAGE 627In this issue of iJACC, Haddad et al. (6) provided a
comprehensive assessment of right heart structure
and function using 2-dimensional (2D) and Doppler
echocardiography in 95 patients with idiopathic,
familial, or drug- and toxin-associated PAH. This
exploratory study was aimed at determining which
parameters act as independent predictors of
outcome and secondly deriving an echocardio-
graphic score that would best predict mortality in
these patients. RV structure was assessed using
linear dimensions and area, whereas function was
determined by right ventricular fractional area
change (RVFAC), tricuspid plane systolic excursion,
and myocardial performance index. In addition, RA
area was assessed throughout the cardiac cycle,
providing total, passive, and emptying fractions, as
well as a value of maximum size. Composite end-
points of death or lung transplantation were
assessed at 1, 3, and 5 years. A range of parameters
were associated with the composite endpoint, and
subsequently RV function as assessed through
RVFAC, RA area index, and systolic blood pressure
collectively provided a strong model for prediction
of mortality and were considered the optimal vari-
ables to generate a “right heart” score. Importantly,
there was also a strong association between RA
active emptying fraction and the composite end-
point. Furthermore, when the right heart score was
validated against the National Institutes of Health
registry score and the REVEAL score, it provided
similar accuracy but superior sensitivity and
speciﬁcity.
It is important to note that this “simple” index is
simple from a practical perspective in that a single
investigation is all that was required; however, theﬁndings reﬂect the complexity of the right heart.
RVFAC was more readily associated with outcomes
than tricuspid plane systolic excursion, highlighting
the fact that this measurement takes into account
both radial and longitudinal functions. It is therefore
sensible to assume that indexes that better reﬂect
overall RV function will improve the prognostic
value of the right heart score. Recent advances in
quantitative analysis such as strain imaging have
been shown to relate strongly to RV function in pa-
tients with PAH (7). Although current 2D technology
only provides accurate RV longitudinal informa-
tion, a recent study using multiple views to provide a
more comprehensive assessment of RV mechanics
was proposed and successfully identiﬁed RV dys-
function in patients with PAH (8). Other techniques
such as deformation-volume relationships are
time consuming but again may provide additional
value. 3D imaging of the RV is now feasible, and
hence, RV ejection fraction and 3D strain are
becoming part of the noninvasive armamentarium.
Although RV size did not show any strong associa-
tion with outcome, it is clear that a 3D technique
would allow for a more detailed understanding of
complex RV remodeling (9). It is also apparent that
these tools have recently been applied to the RA
(10,11), and therefore, a greater depth of knowledge
pertaining to the RA-RV relationship is rapidly
becoming reality.
The next logical step should aim to use the ad-
vances in echocardiography without detracting from
the “simple” nature of the index. It is important to
commend Haddad et al. (6) for this work and for
reminding us that “simple” can still reﬂect
complexity but also to be aware that any index needs
to be sensitive to responses to therapy and disease
progression while remaining valid and reproducible.
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